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Evaluation of a real-time virtual intervention to
empower persons living with HIV to use therapy
self-management: study protocol for an online
randomized controlled trial
José Côté1,2*, Gaston Godin3, Yann-Gaël Guéhéneuc4, Geneviève Rouleau1, Pilar Ramirez-Garcìa2, Joanne Otis5,
Cécile Tremblay6,7 and Ghayas Fadel8
Abstract
Background: Living with HIV makes considerable demands on a person in terms of self-management, especially as
regards adherence to treatment and coping with adverse side-effects. The online HIV Treatment, Virtual Nursing
Assistance and Education (Virus de I’immunodéficience Humaine–Traitement Assistance Virtuelle Infirmière et
Enseignement; VIH-TAVIE™) intervention was developed to provide persons living with HIV (PLHIV) with
personalized follow-up and real-time support in managing their medication intake on a daily basis. An online
randomized controlled trial (RCT) will be conducted to evaluate the efficacy of this intervention primarily in
optimizing adherence to combination anti-retroviral therapy (ART) among PLHIV.
Methods/design: A convenience sample of 232 PLHIV will be split evenly and randomly between an experimental
group that will use the web application, and a control group that will be handed a list of websites of interest.
Participants must be aged 18 years or older, have been on ART for at least 6 months, and have internet access. The
intervention is composed of four interactive computer sessions of 20 to 30 minutes hosted by a virtual nurse who
engages the PLHIV in a skills-learning process aimed at improving self-management of medication intake.
Adherence constitutes the principal outcome, and is defined as the intake of at least 95% of the prescribed tablets.
The following intermediary measures will be assessed: self-efficacy and attitude towards antiretroviral medication,
symptom-related discomfort, and emotional support. There will be three measurement times: baseline (T0), after 3
months (T3) and 6 months (T6) of baseline measurement. The principal analyses will focus on comparing the two
groups in terms of treatment adherence at the end of follow-up at T6. An intention-to-treat (ITT) analysis will be
carried out to evaluate the true value of the intervention in a real context.
Discussion: Carrying out this online RCT poses various challenges in terms of recruitment, ethics, and data
collection, including participant follow-up over an extended period. Collaboration between researchers from clinical
disciplines (nursing, medicine), and experts in behavioral sciences information technology and media will be crucial
to the development of innovative solutions to supplying and delivering health services.
Trial registration: CE 11.184 / NCT 01510340
Keywords: Randomized controlled trial, Web-based study, People living with HIV, Self-management program,
Adherence, Anti-retroviral therapy
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The morbidity and mortality rates of people infected
with HIV has declined dramatically since the advent in
1996 of combination antiretroviral therapy (ART) and
the use of appropriate prophylaxis against opportunistic
infections [1,2]. Formerly classified as a terminal illness,
HIV infection is today considered a chronic disease. Al-
though ART cannot eradicate HIV, existing antiviral
therapies suppress viral replication and thus make it
possible to maintain and improve the immune function
of infected individuals. However, adherence to treatment
is key to preventing treatment failure and the develop-
ment of antiviral drug resistance.
A certain degree of non-adherence might have an ef-
fect on treatment outcome, depending on pattern and
medication. For example, individuals who skip treatment
on consecutive days (sustained interruption) are at
higher risk of presenting a detectable viral load than are
those who skip an equal number of doses non-
consecutively (interspersed missed doses) [3,4]. Further-
more, it has been recognized that, because of their long
half-lives and potency, certain types of medication, such
as non-nucleoside reverse-transcriptase inhibitors
(NNRTIs) and boosted protease inhibitors (PIs), are
more forgiving of moderate levels of adherence [5,6].
Notwithstanding, poor adherence remains a major risk
factor in virologic failure and the development of resist-
ance [7]. Therefore, developing interventions to boost
and sustain ART adherence has become a crucial object-
ive in the field of HIV management.
Interventions to foster adherence
Treatment adherence immediately arose as a key issue
after the introduction of ART. The need to develop ap-
propriate support interventions to foster adherence was
crucial at the time, and it remains strong today, despite
the fact that regimens have grown simpler [8] (smaller
doses, fewer pills) and easier to tolerate over time. After
all, ART constitutes a lifetime commitment on the part
of the infected individual. Since 2003, the results of pilot
studies have demonstrated the feasibility of interventions
to influence adherence [9-12], and some interventions
evaluated in experimental studies have shown a potential
to optimize adherence [13-22]. A systematic review of
treatment adherence interventions intended for persons
living with HIV (PLHIV) [23] suggested that individual
interventions targeting medication management skills
were associated with improved adherence outcomes (n =
10 studies). In their systematic review of interventions
intended to optimize medication adherence among other
groups, Haynes et al. [24] indicated that only 36 of the
83 interventions examined were associated with
improved adherence. Kripalani et al. [25] reported simi-
lar results in their review focused on a chronically illgroup. Of the 37 randomized trials reviewed, 20 pro-
duced a significant change in at least one adherence
marker, and over half of these interventions (n = 11) had
an effect on clinical markers.
In light of these mixed results, Haynes et al. [24]
stressed the need for novel approaches to support treat-
ment adherence. Recent reviews by Bärnighausen et al.
[26] and Horvarth et al. [27] have suggested that inter-
ventions assisted by information and communication
technologies, such as text messages sent via mobile
phone, could effectively increase adherence in sub-
Saharan Africa. Thus, tailored interventions and the use
of information technologies open up interesting possibil-
ities for developing innovative interventions geared to
optimizing treatment adherence and reaching a broader
patient base across vast geographical areas.Information and communications technologies: a
promising avenue for providing support to people living
with HIV
In the field of health education, there is a growing and
apparently inevitable tendency to use information and
communication technology (ICT), such as web applica-
tions and software systems, as interactive means of in-
formation transmission [28-31]. These technologies
make it possible not only to present a large amount of
information in a more user-friendly way, but also for
users to access, at their convenience, information better
adapted to their own needs. This characteristic greatly
facilitates the active learning process at the heart of the
development and reinforcement of health behavior self-
management skills [32-34].
Tailored interventions are defined as change strategies
intended for a given person based on their specific char-
acteristics, identified beforehand through an individual
evaluation [35,36]. What distinguishes these interven-
tions is the fact that the change strategy targets the needs
of one particular person rather than those of a group,
and that the messages and feedback conveyed are
adapted to individual factors related to a given health be-
havior [37]. This makes it possible to achieve more sig-
nificant results as the person feels more engaged by the
messages and in turn engages more readily in the pro-
posed strategies [38-40].
The combined benefits of tailored interventions and of
the use of ICT make this type of intervention more ef-
fective than traditional health education interventions
[34]. Studies have confirmed the efficacy of this type of
intervention on the adoption of various health behaviors,
including quitting smoking [41-45], reducing the amount
of fat in the diet [46,47], increasing the consumption of
fruit and vegetables [48,49], and engaging in early cancer
detection [50,51]. In the field of HIV, ICT has been used
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terms of sexual practices or use of syringes [52-56].
In their review of computer-assisted tailored interven-
tions delivered online, Lustria and colleagues [57] identi-
fied 30 studies (out of the 503 found between 1996 and
2007) where the applications targeted four health beha-
viors (nutrition (n = 10), physical activity (n = 7),
tobacco use (n = 7), alcohol consumption (n = 3)) , as
well as ‘other behavior’ (n = 3). In their analysis, they
sought in particular to describe the mechanisms used to
put into operation the concept of tailored interventions
and to implement online interventions. They found a
wide variety of approaches being used, and highlighted
the importance of pursuing research in this domain.
The systematic review (n = 24 studies) by Murray
et al. [58] supported the effects of computer-assisted
interventions for individuals living with a chronic condi-
tion in terms of knowledge acquisition, changes to health
behavior, self-efficacy, perceived social support, and other
clinical markers. These technologies have been used for
individuals living with asthma [59], diabetes [60-62], heart
disease [63-66], and HIV [67,68]. On the whole, what
emerges is that these technologies can be used with a
variety of groups of different ages [69-73]. The use of
different ICTs in the field of health education shows
that they are effective in transferring knowledge and
developing the skills needed for health promotion and
management of the demands inherent to illness [29,30].
Regarding access to these technologies, 175 million
adults [74] in the USA reportedly used the internet in
2010 to obtain health-related information. According
to the results of a Harris poll, 88% of adults online
have searched the web for such information. Moreover,
in 2009, Statistics Canada [75] reported that 80% of
Canadians 16 years of age or over used the internet at
home for personal reasons, and this percentage represented
21.7 million users. These Canadian data also showed
that 70% of people used the internet to search for medical
information and for health-related purposes (74% of women
and 66% of men). In Quebec, the second most densely
populated province in Canada, the NETendances survey
conducted by CEFRIO-Léger Marketing [76] showed that
79.1% of Québécois had used the internet in the previous 7
days.
To date, web applications have been developed to sup-
port primary and secondary prevention efforts for
tobacco use, physical activity, nutrition, use of certain
health examinations, and the adoption of safe sexual
behaviors. However, few tailored interventions have used
this educational approach in tertiary prevention to support
treatment adherence. Living with HIV makes consider-
able demands on a person in terms of self-management,
especially regarding adherence to lifelong therapy and
coping with adverse side-effects. PLHIV must play amore active role in this management, thus breaking with
the traditional paternalistic health model in which the
patient has a more passive role. Instead, the health pro-
fessional becomes a care partner and mentor who
empowers the PLHIV to take charge of the situation.
Consequently, it is imperative that innovative ways
should be found to provide assistance and follow-up to
PLHIV. From this point of view, we believe that the use
of ICTs can constitute an effective approach to treat-
ment management by providing PLHIV with support in
the form of messages that target and are adapted to their
needs. Such virtual follow-up would be complementary
to existing clinical follow-up. Given the persistent or
long-term nature of ART, finding new ways to support
PLHIV who are on such treatment seems an avenue
worth exploring.
Goal
Drawing on the recommendations of the National Insti-
tutes of Health (NIH) [77] regarding the four phases of
research on interventions in the field of health sciences,
we plan to evaluate the efficacy of an online virtual
intervention in optimizing adherence to antiretroviral
medication intake by PLHIV (phase III). The study will
rest on preliminary work (phases I and II) that served to
clearly identify the predictors of treatment adherence by
PLHIV [78], and will develop and validate the content of
the intervention in question [79], and create the corre-
sponding web application [80].
Preliminary work
Based on a philosophy of empowerment, the HIV Treat-
ment, Virtual Nursing Assistance and Education (Virus
de l’immunodéficience Humaine–Traitement Assistance
Virtuelle Infirmière et Enseignement; VIH-TAVIETMa)
web application makes it possible to develop and
strengthen the skills needed for PLHIV to self-manage
their treatment while boosting their sense of self-efficacy
with respect to the daily intake of medication [80]. This
application was developed in accordance with the sys-
tematic analytic process proposed by Bartholomew et al.
[81,82], and rests on explanatory and predictive models
of health behaviors [79]. The specificity of this applica-
tion lies in its action mechanism based on Bandura’s the-
ory of behavioral change [83], which targets the
development and reinforcement of skills, that is, the
individual’s ability to act.
The web application is composed of four interactive
computer sessions hosted by a virtual nurse who engages
the PLHIV in a skills-learning process aimed at improv-
ing self-management of medication intake. The skills
covered (motivational, self-awareness, problem-solving,
emotion-regulation, social) allow the PLHIV to integrate
the therapeutic regimen in their daily routine, manage
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might interfere with medication intake, interact with
health professionals, and mobilize their social support
network. Aside from delivering tailored teaching, the vir-
tual nurse refers to the experiences of other individuals
who coped with similar situations successfully. During
these sessions, the virtual nurse provides feedback and
positive reinforcement on the individual’s personal style
and methods and on the acquired skills. The interactive
system is designed to allow repeated applications and
backtracking depending on the individual’s needs. More-
over, at each session, feedback is provided on the signifi-
cant elements of the previous session. The individual’s
profile is personalized as a function of their needs and
characteristics, thus giving the profile a tailored fit. Fur-
thermore, the computer innovation underlying the vir-
tual intervention allows to create new pages , thus
allowing the system administrator the flexibility to add
or modify page models and content depending on the
context.
Methods
Ethics approval
The study has been approved by the Research Ethics
Board of the Université de Montréal and the Research
Center of the Centre Hospitalier de l’Université de
Montréal.
Design
We opted for an online randomized controlled trial
(RCT) to evaluate the efficacy of the virtual intervention
(web application) primarily in influencing ART adher-
ence. Adherence is a behavioral indicator that can be
predicted in part by cognitive and affective variables,
particularly sense of self-efficacy and attitude towards
antiretroviral medication intake [78]. These variables are
in turn explained by perceived social support, relation-
ship with health professionals, and absence of adverse
effects. These intermediate variables, which are the tar-
gets of our intervention, will allow effective change in
the short term. They constitute mediators capable of
explaining the intervention’s effect on adherence. There
will be three measurement times: baseline (T0), after 3
(T3) and 6 months (T6) of baseline measurement. Parti-
cipants will be drawn from a convenience sample and
will be randomly assigned either to an experimental
group that will use our web application, or to a control
group that will be presented with a list of various web-
sites of interest.
Hypotheses
The primary hypothesis is that a higher proportion of
participants in the experimental group will prove
treatment-adherent at T6 compared with the controlgroup. The explanatory hypothesis is that the following
variables are mediators that can explain the interven-
tion’s effect on adherence: sense of self-efficacy, attitude
towards antiretroviral medication intake, degree of
symptom-related discomfort, and perceived social sup-
port (T0, T3, T6).
Sample
We aim to recruit a sample of 232 participants, that is,
116 per group. The PLHIV who will participate in the
study must be at least 18 years of age and on ART for at
least 6 months. The reason for the latter criterion is that
we wish the therapy-management intervention to focus
on adherence over time rather than on treatment initi-
ation. Internet access is another inclusion criterion. This
will introduce a selection bias in the study; however, the
bias will be offset by the inherent value in evaluating an
innovative service-delivery method that, in the near fu-
ture, could reach a vast number of people at low cost
and, thus, constitute an important option for providing
follow-up to groups with a chronic health problem. In
this study, both the experimental group and the control
group will be composed of PLHIV with similar charac-
teristics, who have internet access and who use it to ob-
tain information relative to their health condition.
The sample size was estimated based on the studies by
Tuldrà et al. [84] and Pradier et al. [18] carried out with
PLHIV, and on the systematic review by Haynes et al.
[24] of adherence-related interventions intended for
various groups. In the study by Tuldrà et al. [84], there
was a difference of 25 percentage points between the
control group and the experimental group in terms of
treatment adherence (69% vs. 94%, respectively). For
Pradier et al. [18], the proportion of treatment-adherent
participants was 58% in the experimental group and 63%
in the control group at the start of the study, and 75%
and 60% respectively after the intervention. We calcu-
lated our sample size on the assumption that the pro-
posed intervention (the web application) will increase
the percentage of treatment-adherent participants in the
experimental group by 20%. The percentage of treatment-
adherent participants at the start of the study will be the
same as that reported by Godin et al. [78] (that is, 50%),
given that our recruitment pool is very similar to theirs.
This is a conservative assumption given that the variance
in the difference between the two proportions will be
larger, with the benchmark proportion set at about 50%.
Consequently, the sample size required to detect a dif-
ference of 20% (50% treatment-adherent participants in
the control group versus 70% in the experimental group)
will be larger than for other scenarios with the same
20-point difference. Hence, to detect a difference of 20
percentage points at 80% power and a χ2 test two-tailed
α value of 0.05, the required sample size is 186 participants,
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rate (that is, the same rate seen in the studies by Goujard
et al. [14] and Tuldrà et al. [84]), the sample size has
been set at 232 participants. With a sample of 186 par-
ticipants completing the study, the statistical power will
be enough to detect a moderate effect on the intermedi-
ate variables. In particular, with n = 186, an α value of
0.05 (two-tailed Student’s t-test) will allow detection of
the difference between the two percentages, correspond-
ing to a standard deviation of 50% and power of greater
than 90%.
Experimental conditions
The virtual intervention consists of four computer ses-
sions of 20 to 30 minutes in length. There will be a
1-week interval between sessions to ensure the progressive
acquisition and consolidation of skills, thus, access will
be controlled and pre-determined within this interval. It
will be possible at all times for participants to revisit pre-
vious sessions. Access will be unlimited in terms of inten-
sity, frequency, and time of use throughout the duration
of the study. Delivering an intervention by computer
affords a key advantage in that it allows complete control
of the content. Moreover, the intervention’s parameters
are recorded, thus making it possible to obtain a reliable
picture of the actual intensity, duration, and frequency of
the intervention. These data will be available for subse-
quent analyses.
Control group
Participants in the control group will be invited to con-
sult, at their convenience and from the location of their
choice, a list of pre-determined websites offering infor-
mation on antiretroviral medications, their side-effects,
and their interactions.
Measurement
Adherence will constitute the principal outcome, and for
the purposes of the study, it will be evaluated through a
self-administered questionnaire that was developed for
and validated on the target population in accordance
with recommendations relative to the measure of treat-
ment adherence [85]. The questionnaire comprises seven
items that serve to determine how many times a person
forgets to take their medication. The questionnaire is
designed to place the respondent in a context where
events and situations could lead to lapses. The question-
naire’s validity was assessed (sensitivity 71%; specificity
72%; correct classification 72%; odds ratio 6.15) using
immunologic (CD4 count) and virologic (viral load)
parameters as validation criteria. Adherence was defined
as the intake of at least 95% of the prescribed tablets. Al-
though there is no clear minimum cut-off point defining
what constitutes sufficient ART adherence for achievingoptimal treatment efficiency [5], this is generally set at
between 90% and 95% [86]. Self-reported viral load and
CD4 counts will also be recorded.
The intermediary measures will be assessed by means
of validated instruments. Self-efficacy regarding medica-
tion intake will be measured using 12 items rated on a
5-point Likert scale (here is an example of an item: “I
can take my antiretroviral medications even if I’m in the
company of people who don’t know I’m seropositive”).
These items are adapted from a scale developed by
Godin et al. [78] and have previously been used on a
large sample (n = 399). To adapt the instrument to our
context (that is, antiretroviral medication intake), the
items have been reformulated by expert consensus fol-
lowing the results of a focus group and of a literature re-
view, and on the basis of Bandura’s theoretical model of
self-efficacy. A content validation has also been carried
out.
Attitude toward medication intake will be evaluated
through six items rated on a five-point Likert scale.
These items emerged from focus groups of PLHIV who
were on treatment. A preliminary version of the instru-
ment was tested on 35 PLHIV. The scale was previously
used on a large sample (n = 399) [78], obtaining a Cron-
bach’s α coefficient of 0.83 and a test-retest reliability co-
efficient of 0.72.
Symptom-related discomfort will be measured using
the Self-Completed HIV Symptom Index [87]. This 20-
item instrument determines using a scale of 1 to 4
whether symptoms are present (0 = absence) and the de-
gree of discomfort experienced. The instrument has
been validated on 188 PLHIV, and it was found to have
acceptable psychometric properties, including good con-
struct validity.
Social support will be evaluated using the Medical
Outcome Survey [88,89]. One dimension of social sup-
port will be measured by subscale of emotional support,
which has eight item, each of which is rated on a five-
point Likert scale. The instrument has been found to
have good content validity and appreciable internal
consistency.
A sociodemographic questionnaire will cover personal
characteristics such as sex, age, family situation, level of
education, employment situation, number of children,
and questions about HIV, the therapeutic regimen, and
presence of symptoms.
Recruitment and online data collection
The study will be conducted entirely online. The project
will be advertised on the websites of resources available
to PLHIV, where a hyperlink and a banner will be
inserted to redirect parties interested in participating in
the online research. The targeted resources include part-
ner clinics, community agencies, and other organizations
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PLHIV. In addition, health professionals and stake-
holders will be invited to inform their PLHIV about the
study. To promote the project among PLHIV, different
communication strategies will be used: 1) traditional
methods, such as poster and information brochures; and
2) technological or virtual methods, by advertising the
study on websites of organizations (medical clinics, asso-
ciation for PLHIV) that are often visited by PLHIV.
Individuals who will visit the study’s website will view
a short video clip of testimonials by a few PLHIV, then
they will be given information on the study. After
accepting the conditions of the study and consenting to
take part in it, they will sign up for the study by provid-
ing an email address and a pseudonym. Each participant
will be validated through an email address check. Once
this step is completed, a hyperlink will be emailed to
allow participants to access the first questionnaire online
on the website, and only after having completing this
questionnaire will they be randomly assigned by the
computer system to the experimental group or the con-
trol group. Participants in the control group will be
invited to consult pre-determined websites that offer in-
formation on ART and its associated side-effects. Partici-
pants in the experimental group will be offered the
virtual intervention through the web application. At 3
and 6 months after the initial measurement, participants
will complete the online questionnaires again. A re-
minder to this effect will be emailed to them in the days
prior to the scheduled measurement. Participants will be
compensated for their time spent on the study with a
gift certificate for each measurement time completed.
Type of analysis used
To establish whether the experimental and control
groups are equivalent, the means and medians of the
continuous variables and the frequency distributions of
the discrete variables will be compared using descriptive
analyses. The principal analyses will focus on comparing
the two groups in terms of treatment adherence (the
study’s main outcome, considered as a binary variable
with adherent being ≥ 95% and non-adherent < 95%) at
the end of follow-up at T6. An intention-to-treat (ITT)
analysis will be carried out to evaluate the true value of
the intervention in a real context. Consequently, in the
following analyses, all participants will be assessed in
their respective randomization group as to whether they
are following the procedure or have been lost to attrition
during follow-up. In accordance with the principles of
ITT, participants who drop out and those for whom
there is no adherence measure at T6 will be considered
as non-adherent.
The primary hypothesis is that the VIH-TAVIE inter-
vention will increase the proportion of treatment-adherent patients at T6. This hypothesis will be tested
using a χ2 test with 1 degree of freedom. If preliminary
analyses show that the two groups differ on certain char-
acteristics, multivariate logistic regression will be used to
adjust the intervention’s effect on these characteristics,
which will be considered as potential confounding vari-
ables. In this case, the two-tailed Wald’s test will be used
to test the intervention’s adjusted effect.
For the secondary analyses, the two groups will be
compared on all the repeated measures of adherence
(T3 to T6) using a generalized estimating equation
(GEE) approach that generalizes the logistic regression
for longitudinal data with repeated measures of the bin-
ary measure [90]. We will assume that the covariance
matrix has an auto-regressive structure of order = 1 to
account for inter-correlations between repeated mea-
sures (over the course of follow-up) with the same parti-
cipants. The difference between repeated measures of
adherence (T3 and T6) will constitute the binary
dependent variable. The binary intervention indicator,
the indicator of time since the follow-ups (3 and 6
months) and, if necessary, the confounding variables,
will be included as independent variables. Finally, the
interaction between the intervention effect and the time
effect will be added to the GEE model and will be tested
to verify whether the intervention’s effect on adherence
varies over time. In the GEE analyses, a conservative ap-
proach will be used and, accordingly, all missing data for
the dependent variable (adherence) will be replaced with
‘non-adherent’. The same approach will be used to
evaluate the effects of the intervention on the repeated
measures of the intermediary variables. However, given
that these variables will be measured by means of quan-
titative scales, a linear mixed model for repeated mea-
sures of a continuous dependent variable [91] will be
used instead of the GEE model.
Discussion
Challenges of an online randomized controlled trial
Carrying out this online RCT poses various challenges,
particularly in terms of recruitment, ethics, and data col-
lection, including participant follow-up over an extended
period [92].
First, to attract and retain the online participation of
PLHIV interested in the study, the team sought the help
of web design experts. This help led to the development
of a brand image (concept of branding) by an artistic
director, who created a logo that would carry the image
of the study and be easily recognizable by our target
group. This branding set the tone (in terms of color and
visuals) for our website pages, which were created to be
visually attractive to participants. More specifically, upon
reaching the first page of the website, participants will
listen to testimonials by a few PLHIV about their own
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the web in search of health-related information. Aside
from being an interesting and dynamic visual tool, testi-
monials have been used to allow potential participants
to identify with the intervention, and to humanize and
personify the web-based study. These testimonials also
have the potential to strengthen the branding of the
intervention. Then, in a short video clip, the research co-
ordinator and a project spokesperson will present infor-
mation on the study, including its aim and inclusion
criteria, and explain what participation entails.
Various communication strategies will be used to pro-
mote the study among PLHIV. First, traditional methods
of dissemination will be used, such as publishing adver-
tisements or short articles in magazines aimed at PLHIV,
and distributing information brochures and posters to
the clinics and community organizations targeted. Sec-
ond, an internet-based approach will also be used, con-
sisting of posting a hyperlink to our study on the
websites of organizations (medical clinics, association for
PLHIV, community groups) frequently visited by PLHIV.
In this regard, Birnbaum [93] suggested that such orga-
nizations should run advertisements in their electronic
newsletters. A list of targeted internet media will be
compiled in collaboration with key informants working
with PLHIV in community organizations. There are
other methods of online recruitment, such as reaching
target groups through chatrooms, sending e-mails to
pre-established lists of participants, or posting banners
on popular websites [94,95]; however, we will not use
these latter strategies in our study. According to Noseck
et al. [95], even if posting advertising banners is a popu-
lar way of promoting a study, it remains a costly means
of recruitment and ‘is not the most effective at netting
traffic’ ([95], p. 167).
One of the risks that remain difficult to control or pre-
vent in a virtual environment is having the same person
participate more than once in a given study [93,95,96].
Although the incidence of this happening has been
shown to be small, at 3%, [93,97], certain strategies can
be used to detect or prevent it and reduce the risk of its
occurrence, including warning participants to register
only once, asking for an email address and a password at
registration, and filtering data that seem to be identical
[93,95,96].
The ethical aspects of online studies have been dis-
cussed by various authors [98-101]. The topic has
received special attention because of the online research
environment in itself, where there’s no direct interaction
between researchers and participants [95,96]. Among
other things, consent to participate can be presented in
the form of a statement to be read and checked off be-
fore clicking on a button labeled ‘I accept’. A button la-
beled ‘withdraw’ or ‘quit the study’ [95] will also beaccessible to allow participants the freedom to drop out
of the study at any time. As proposed by Hewson [99]
and Nosek et al. [95], a ‘debriefing page’ and contact in-
formation for a resource person in the event of ques-
tions or problems will also be provided. The information
must be presented in such a way as to properly inform
participants but without overwhelming them with data,
which could cause difficulties and discourage subjects
from participating.
The security and confidentiality of electronic data in
online studies are serious concerns that necessitate the
implementation of stringent measures. The data col-
lected through the online questionnaires will be stored
on a secure server located at the research center where
the research work is carried out. Only system adminis-
trators will have access to the data on the server. To
protect the identity of participants, only an email ad-
dress and a pseudonym will be requested from partici-
pants, as this information is necessary to ensure follow-up
and disseminate results, as pointed out by Michalak
and Szabo [100]. Using a firewall, encrypting the data,
protecting passwords, and separating the sociodemo-
graphic data from the experimental data (linking them
through a code) reduces the risk of an unauthorized
third party accessing confidential content [95,101]. A
database has been planned to support the subsequent
direct transfer of the data to analysis software (the SPSS
package; SPSS Inc., Chicago, IL, USA) in order to facili-
tate data analysis.
As emphasized by Bull et al. [94], online longitudinal
evaluations entail following up participants and complet-
ing various measures. According to Bull et al. [94] and
Bennett and Glasgow [92], online studies have a lower
retention rate than that of traditional studies, and attri-
tion rates of 40% are not uncommon. However, Schubart
et al. [102] and Bull et al. [103] highlighted a number of
elements that foster a high retention rate in online stud-
ies, including the availability of a health professional to
provide feedback, the dynamic qualities of the study
website, and the inclusion of a clinician coach, such as a
nurse, in the intervention. All of these will be considered
in this study.
For the purpose of encouraging participants to con-
tinue with the study, reminder e-mails (maximum of
three to four) will be sent out at 7-day intervals prior to
measurement. Bull and colleagues [94] noted that e-
mails alone were not sufficient to communicate with
participants, and that a variety of communication modes
should be used. They suggested that participants should
be asked to provide other contact details such as home
and mobile telephone numbers, and a home address.
According to these authors, a balance must be struck be-
tween guaranteeing confidentiality and ensuring follow-
up. Because the technology we plan to use is complex
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sign a resource person (technical support) to help users
in this regard. According to Paul and colleagues [101],
this constitutes a key source of support if the research
budget allows it.
A research project that unfolds entirely online necessi-
tates that all parties share an understanding of the spe-
cific terminology used by the various experts involved
and of the role played by the professionals in each of the
project’s teams (computer programming, multimedia,
clinical). It is necessary to ‘think virtual’, that is, to make
sure that procedures applied in the real world are oper-
ational online. Transposing research procedures to an
entirely virtual research intervention entails anticipating
the entire sequence of participation and follow-up of the
target persons. Making this shift is not easy. Indeed, the
absence of a common language between research, clin-
ical, and web media teams, as well as a mutual misun-
derstanding of the needs of each group (researchers
versus tech support teams, for instance), calls for a great
deal of clarification and numerous meetings to make the
technical operations required by the project possible.
This collaboration between researchers from clinical dis-
ciplines (nursing and medicine), experts in behavioral
and educational sciences, and information technology
and media experts is crucial to the development of in-
novative solutions to supplying and delivering services
to those who need them.
However, without the contribution of community part-
ners and other clinical collaborators, such a study could
not be carried out easily. Their support and expertise are
invaluable at all levels, particularly in planning and
developing the different stages of the online study (for
example, using testimonials was our partners’ idea). Our
partners will also be involved in promoting the study,
recruiting participants, and ultimately transferring and
implementing the virtual intervention.Trial status
Data collection was started in February 2012.Endnote
aThe acronym VIH-TAVIE (Virus de l’immunodé-
ficience Humaine–Traitement Assistance Virtuelle Infir-
mière et Enseignement) contains a wordplay in French
that can be rendered in English as ‘live your life’.
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